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Abstract
Background: Alternative splicing increases proteome diversity by expressing multiple gene isoforms that often
differ in function. Identifying alternative splicing events from RNA-seq experiments is important for understanding
the diversity of transcripts and for investigating the regulation of splicing.
Results: We developed Alt Event Finder, a tool for identifying novel splicing events by using transcript annotation
derived from genome-guided construction tools, such as Cufflinks and Scripture. With a proper combination of
alignment and transcript reconstruction tools, Alt Event Finder is capable of identifying novel splicing events in the
human genome. We further applied Alt Event Finder on a set of RNA-seq data from rat liver tissues, and identified
dozens of novel cassette exon events whose splicing patterns changed after extensive alcohol exposure.
Conclusions: Alt Event Finder is capable of identifying de novo splicing events from data-driven transcript
annotation, and is a useful tool for studying splicing regulation.
Background
Alternative splicing is an important level of gene regula-
tion that greatly contributes to proteome diversity [1]. It
enables one gene to produce multiple isoforms that can
have different biological functions. In humans, more than
90% of genes encode multiple protein isoforms [2], and
many diseases are caused by the dysregulation of splicing
patterns [3]. Traditionally, EST (Expressed Sequence
Tags) databases and microarray technologies have been
utilized to study splicing regulation [4-7]. In recent years,
high-throughput RNA sequencing (RNA-seq) technology
has revolutionized functional genomics by offering the
most comprehensive and accurate measurements of
RNAs. In addition to previously known splicing events,
RNA-seq technology can be used to identify novel spli-
cing events.
Many bioinformatics tools have been developed to
derive splicing patterns from RNA-seq data. For instance,
dozens of strategies have been designed for aligning
RNA-seq reads. Using various strategies, such tools,
including TopHat [8], MMES [9], SpliceMap [10], Split-
Seek [11], G-Mo-R-Se [12], GSNAP [13] and SAW [14],
enable alignment of short sequencing reads over splice
junction sites even across large intronic regions. Based
on such splicing-sensitive alignments, follow-up algo-
rithms, such as Cufflinks [15] and Scripture [16] have
been developed to reconstruct transcript isoforms using a
genome-guided approach. Although the idea of recon-
structing the whole transcriptome is intriguing, a quanti-
tative estimate of the expression levels of each isoform is
difficult, particularly for transcripts expressed at low
levels and/or when more than a few isoforms exist. In
addition, isoform-based approaches increase the com-
plexity of studying splicing regulation when many iso-
forms are present in the sample. Event-based approaches,
however, only focus on the inclusion and exclusion of
individual splicing events, regardless of membership in
different isoforms. This greatly reduces the computa-
tional complexity, and offers a direct path for studying
splicing regulation. Based on the sequencing reads
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supporting inclusion and exclusion events, MISO (mix-
ture of isoforms) [17] is designed to estimate the percen-
tage of inclusion for every previously documented
alternative-splicing event in a sample. It further offers a
probabilistic framework for detecting differentially regu-
lated exons, and provides functional insights into pre-
mRNA processing.
One requirement for implementing MISO is to provide
a pre-defined alternative event annotation. Such an anno-
tation heavily relies on previous knowledge, and is not
complete or even available for many species. For
instance, in the official MISO release, alternative splicing
annotation library [17] is only available for human,
mouse, and Drosophila genomes, and does not allow
event-based analysis on datasets from other species. In
addition, even for the species whose alternative splicing
has been heavily investigated, identifying novel splicing
events can be important. Therefore, having a tool for
detecting novel splicing events directly from RNA-seq
data is desirable.
In this study, we developed a tool, Alt Event Finder, for
generating de novo annotation for alternative splicing
events from a map of transcripts and isoforms recon-
structed from RNA-seq experiments. In conjunction with
upstream alignment and isoform reconstruction tools, we
demonstrated that Alt Event Finder has the ability to
identify novel cassette exon events that are not documen-
ted in the established databases. We evaluated the perfor-
mance of this strategy with different combinations of
alignment and transcript reconstruction algorithms,
using a human dataset where alternative splicing events
have been extensively investigated. We further imple-
mented this tool on an RNA-seq dataset from rat gen-




As shown in Figure 1A, the input to Alt Event Finder is a
mixture of RNA isoforms identified from transcriptome
reconstruction tools, such as Cufflinks [15] or Scripture
[16]. The output is a list of alternative splicing events
directly derived from isoform annotation. Alt Event Fin-
der includes two major steps. First, based on a GTF or
BED file for isoform annotation, the unions of the exon
regions are split into the smallest units that do not over-
lap with each other in the genome space, or minimum
non-overlapping exon units. This design is similar to the
PSR (probe selection regions) definition for Affymetrix
exon arrays [18], and can reflect the complexity of the
exon structures where alternatively spliced exons from
the same gene may overlap (i.e. alternative donor or
acceptor sites). Second, individual transcript isoforms
(identified from transcriptome reconstruction tools such
as Cufflinks and Scripture) will be projected to the non-
overlapping exon units (Figure 1B). The number of iso-
forms containing each unit is recorded. Special strings of
such numeric patterns will be used for deriving different
types of splicing events. For instance, for a gene with two
isoforms, a string of [2-0-1-0-2] indicates the presence of
a cassette exon. Although this report focuses on cassette
exons, such simple design allows extension to other types
of events easily.
Alternative splicing event annotations from human liver
data
To test the performance of our strategy, we implemented
Alt Event Finder on a RNA-seq dataset derived from
human primary hepatocytes; the RNA-seq experiment
was conducted using the SOLiD 5500×l system (Life
Technologies). The dataset consists of 7 pairs of samples
derived from 7 individuals. Each pair includes a drug
exposed sample and a control sample. To test the perfor-
mance of Alt Event Finder on data with various sequen-
cing depths, in addition to the 14 RNA-seq samples, we
created 7 patient-specific datasets by merging the
exposed and control samples from the same individual;
and 1 hepatocyte-specific dataset by merging all the 14
samples together.
We used BFAST [19] as the primary aligner of short
reads, due to its higher sensitivity on color-space data
[20]. The alignment was conducted on both genomic
DNA sequences and a junction library including all the
combinations of known junction boundaries (within a
100 kb span) annotated in the UCSC Gene database. The
total number of mappable reads in each sample ranged
from 6.6 million to 19.5 million. We then used Cufflinks
[15] to reconstruct transcript isoforms. From that, we
applied Alt Event Finder. The number of identified alter-
native splicing events increased as a function of depth of
coverage (Figure 2A); events ranged from 433 to 1,049 in
individual samples, from 761 to 1,298 for patient-specific
datasets (combining control and treated data), and was
1,771 for all the samples combined.
To evaluate the performance of the proposed strategy,
we compared our data-derived events with known alter-
native splicing events documented in the MISO release
(based on UCSC hg19 assembly) [17]. For each sample,
we calculated a rate of known events (RKE), which mea-
sures the percentage of identified events that were in the
known splicing events annotation, and a recall value,
which was calculated as the percentage of known splicing
events that were recovered by our strategy. As shown in
Figure 2B, the rate of known events varies from 0.4 to
0.57. This indicates that a significant portion of splicing
events we detected was not documented in the current
database, although junction reads were found in support
of their existence. The recall values, however, are low,
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ranging from 0.004 to 0.025. This is not surprising since
the known event annotation aims at completeness, and
therefore documents events from many tissues with a
variety of biological conditions; most of these events
should not be present in one tissue under one or two bio-
logical conditions. We further evaluated the relationship
between sequence depth and rate of known events (Fig-
ure 2C) and racall values (Figure 2D). Rate of known
events do not show apparent changes, suggesting that the
genes expressed at lower levels contain a similar percen-
tage of novel events as the more abundant transcripts,
but they require greater sequencing depth to identify.
The recall, however, increases almost linearly with loga-
rithmic transformation of the total number of mappable
reads. These results (Figure 2C and 2D) indicate that
many more events will be identified with deeper
sequenced samples, while the percentage of novel events
doesn’t change. Therefore, more novel events will be
identified from deeper sequenced data.
Figure 3 is the screen shot of one of the novel cassette
exons (chr1: 93073138-93073284) not documented in
either the official MISO annotation library (based on
UCSC hg19 assembly) [17] or the Alt Event track (Figure
3F) in the UCSC Genome Browser (GRCh37/hg19,
Feb. 2009) [21]. As shown in the figure, 40 reads are iden-
tified around this exon (Figure 3ABCD), of which 37 (Fig-
ure 3BCD) support inclusion events (exonic reads on the
alternative exon, and junction reads connecting the
upstream or downstream exon with the alternative exon),
and 3 (Figure 3A) support exclusion events (reads con-
necting upstream and downstream exons directly), respec-
tively. Importantly, the presence of 28 exclusive junction
reads provides a strong evidence for the presence of this
novel event.
Due to the tissue specific nature of gene expression and
alternative splicing, using all the known events in the
human genome cannot fairly evaluate the sensitivity of
the proposed approach. This is either due to the absence
Figure 1 Workflow of the alternative splicing event identification pipeline. A) RNA-seq-derived transcriptome data was aligned using a
customized RNA-seq pipeline based on known splicing junctions or Tophat. Cufflinks or Scripture was used for isoform annotation. Based on the
data-derived transcript annotation, Alt Event Finder was applied to identify the novel alternative events. B) Strategies of Alt Event Finder for de
novo event detection.
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of certain isoforms in a specific tissue, hepatocytes in this
case, or because the overall gene expression levels are too
low to be detected given a specific sequencing coverage.
We therefore removed the events either with low expres-
sion levels, or with extremely unbalanced inclusion/
exclusion ratio, from the overall alt event library. For the
latter, it is possible that the RNA-seq data can only detect
the isoforms with inclusion or exclusion events, but not
both. To fairly evaluate the performance, we derived
exon inclusion and exclusion ratios using MISO, based
on all the annotated splicing events. We further filtered
the annotated events containing no less than 10 reads
supporting inclusion and 1 read supporting exclusion.
After applying this filtering, for the hepatocyte-specific
sample (merging reads from all the 14 samples), 83.4% of
the 39,232 total annotated cassette exon events were
removed. The adjusted recall rate is shown in Figure 4.
Clearly, for individual samples, the recall remains low,
Figure 2 Performance assessment for the Alt Event Finder. A) The total number of identified events increases with sequencing depth. Each
dot corresponds to a sample; the color and the shape of the sample denote its biological condition; the regression line is displayed in dashed
line with an R-squared value of 0.9383; B) Performance for the Alt Event Finder pairing with a customized alignment pipeline and Cufflinks. The X-
axis (rate of known events) is defined by the number of overlapping events divided by the number of data-driven events, and Y-axis (recall) is
defined as the number of overlapping events divided by the number of events in the official MISO annotation library; C) The rate of known
events does not change with sequencing depth; D) The recall rate of the Alt Event Finder increase linearly with the logarithmic transformation of
the total mappable reads. The regression line is displayed in dashed line with an R-squared value of 0.9684.
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ranging from 0.9% to 3.6%. This number increased for
patient-specific samples (merging control and drug treat-
ment for one individual), ranges from 2.6% to 5.0%, and
12.4% for all the 14 samples combined. This low recall
rate may be due to the stringent threshold of Cufflinks,
which aims at maximizing specificity.
Selection of alignment and transcriptome reconstruction
tools
We further evaluated how the performance of the Alt
Event Finder is influenced by the alignment and transcrip-
tome reconstruction tools. For the alignment tool, in addi-
tion to our customized RNA-seq pipeline which focus on
known splicing junctions, we also tested TopHat [8], one
of the most widely used RNA-seq alignment software. For
the transcriptome reconstruction tool, in addition to
Cufflinks [15], which aims at maximizing specificity, we
have also tested Scripture [16], a computational algorithm
aiming at higher sensitivity.
The total number of events identified based on 4 dif-
ferent strategies (Customized RNA-seq pipeline and
Cufflinks, Customized RNA-seq pipeline and Scripture,
Tophat and Cufflinks, and Tophat and Scripture) varies
significantly (Figure 5). At low sequencing coverage,
the customized RNA-seq pipeline (using BFAST and
annotated exon boundaries) consistently identified more
events. When the sequencing depth is higher than
100 million reads, however, our AS identification pipe-
line offers significantly more events when Tophat is
partnering with Scripture (Figure 5). When comparing
two transcriptome reconstruction tools, Scripture offers
higher number of events regardless of the sequencing
depth and sequencing alignment algorithm (Figure 5).
Among all the four strategies, the combination of
Tophat and Scripture at high sequencing coverage iden-
tified highest number of events.
Identify alternative splicing events in the rat genome
We applied Alt Event Finder to study the alcohol-induced
alternative splicing changes in liver tissue, using alcohol-
preferring rats as a model system. Seven female rats were
heavily exposed to alcohol for 10 weeks followed by
Figure 3 Screenshot of one of the novel cassette exon events. The diagram demonstrates reads supporting a cassette exon event that was
not previously documented. This gene locates on the reverse strand. The genomic loci of the cassette exon, the 5’ and 3’ constitutive exon are
chr1: 93073138-93073284, chr1: 93089733-93089891, and chr1: 93070864-93070959, respectively. A) Sequencing reads supporting the junction of
the 5’ and 3’ constitutive exons, which indicates exon exclusion; B) Sequencing reads supporting the junction of the cassette exon and the 3’
constitutive exon; C) Sequencing reads supporting the transcription of the cassette exon; D) Sequencing reads supporting the junction of the 5’
constitutive exon and the cassette exon; E) UCSC gene annotation track; F) Alternative splicing annotation track; G) Human EST track; H) The
cassette exon in UCSC gene annotations. No previous evidence of this cassette exon event was shown in the gene annotations, alternative
splicing event annotations or the EST records.
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2 weeks without alcohol, and another 7 were not subjected
to alcohol exposure (controls). An RNA-seq experiment
was conducted on the liver tissues. After sequence align-
ment using TopHat, 123,017,701 and 92,389,972 total
reads were mapped in the 7 control and 7 alcohol-exposed
animals, respectively. Scripture was used for transcript
reconstruction. Alt Event Finder identified 505 candidate
events with a mixture of multiple isoforms in the com-
bined sample of all 14 rats. With a MISO isoform differen-
tial expression test, we found 75 were alternatively spliced
at Bayesian Factor (BF) [17] larger than 2; this number
implies that it is twice as likely for the events to be alterna-
tively spliced than not. A more stringent cutoff derived 55
events with BF > 5.
Figure 6 shows the Sashimi plots [17] for three events
with apparent alcohol-induced splicing changes in genes
highly expressed in liver tissues, LOC691397 (similar to
PI-3-kinase-related kinase SMG-1), Glycerol kinase, and
CD47 (Figure 6A). For LOC691397, 40 junction-reads
support exon inclusion in the control samples, and 17 sup-
port exclusion. In the alcohol exposed samples, however,
these numbers changed to 8 and 15, respectively. This pat-
tern indicates that chronic alcohol exposure induces
higher relative expression levels of the isoforms without
the cassette exon, with a BF value 15.37. Similarly, CD47
showed lower inclusion ratio after alcohol exposure
(Figure 6C), while alcohol drinking induces exon inclusion
for the glycerol kinase (Figure 6B).
Discussion
In this study, we developed a tool, Alt Event Finder, which
generates splicing event annotations from RNA-seq data.
Most event-based analysis, such as MISO [17], cannot
work without a library of known event annotations. There-
fore they cannot be implemented on a genome for which
annotation is unavailable, such as the rat genome. Even
for a genome for which alternative splicing has been
extensively studied, such as human or mouse, lack of a de
Figure 4 Performance with adjusted known event annotation. The rate of known events and recall values were calculated only based on
the events that have at least 10 junction reads supporting the inclusive event and 1 junction read supporting the exclusive event.
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novo event finding tool limits the power of studying events
that are not previously documented. Alt Event Finder
bridges the gap between event-based analysis and isoform-
based transcriptome reconstruction algorithms, such as
Cufflinks and Scripture. It’s an important addition to the
current AS analysis toolset.
Our algorithm extracts “minimum non-overlapping
exon units” (Figure 1B) from RNA-seq-derived transcript
isoform annotation based on Cufflinks or Scripture, and
further identifies potential alternative events. This strat-
egy greatly increases the flexibility of our methods.
Although the current study focuses on cassette exon, it
can be easily extended for other types splicing events,
such as intron retention, alternative 5’ donor, alternative
3’ acceptor, and so on. This is important because certain
types of events can be more prevalent in specific tissue
types. For instance, cassette exons are dominant in brain
tissues, while alternative 5’ donor and 3’ acceptor events
are more abundant in liver tissues [22].
Alt Event Finder relies on upstream alignment and
isoform reconstruction tools. We have evaluated how
different tool combinations affect the ability to discover
novel splicing events. We found that a customized align-
ment pipeline based on known exon boundaries perform
better in low sequencing coverage (< 100 Million reads),
while TopHat did better for high sequencing coverage.
This is because TopHat derives exon structures mainly
based on the accumulation of RNA sequencing reads.
Since it does not rely on existing exon annotations, at
lower coverage, the data may not have adequate power
to properly identify low expressed exons. For higher
coverage, however, TopHat will not only have enough
power to precisely map the boundaries of known exons,
but also be more suitable for identifying novel exons.
We have also found that we can generally identify more
AS events using Scripture as isoform reconstruction
tool, compared to using Cufflinks, because Scripture
aims at maximizing sensitivity, while Cufflinks aims at
Figure 5 The number of identified events differs with different combinations of alignment and transcript reconstruction algorithms.
Each dot describes a sample. X and Y axes denotes sequencing depth and the total number of identified events. Samples were color-coded
based on their combinations of upstream algorithms.
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specificity. Overall, we recommend using the mapping
algorithm based on known exon annotation and Scrip-
ture combination at a low sequencing depth, and the
TopHat and Scripture strategy with high sequencing
coverage.
To find out the cause of the low recall rate, we inves-
tigated the AS events that were identified with the offi-
cial MISO library but not found in our annotations.
One of the major causes of such events is lack of junc-
tion reads between the cassette exon and constitutive
Figure 6 Sashimi plot for three novel events that are alternatively spliced in rat liver with chronic alcohol exposure. The RNA-seq read
densities supporting inclusion and exclusion events are shown in the figure. The estimated percentage of inclusion for the alternative events
and their estimated confidence intervals are also demonstrated. The Sashimi plot is produced by the MISO package.
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exons, which makes the inclusive isoform not detectable
by Cufflinks and Scripture, but still quantifiable by MISO
since reads are covering the cassette exon. Another cause
is additional alternative spliced 3’ and 5’ sites on a cas-
sette exon event, which make an event in our annotation
different from the official MISO annotation.
Since Alt Event Finder is a data-driven approach, its
power highly depends on the sequencing depth. When the
sequencing depth is low, a lot of junction read will be
missed, and a lot of low expressed exons could be “discon-
nected"; this will significantly decrease the power of the
transcriptome reconstruction algorithm for rebuilding the
isoforms from RNA-seq data, therefore affect the perfor-
mance of Alt Event Finder. Therefore, when possible,
increasing the sequencing depth can significantly elevate
the power of novel event identification.
When deep sequencing data is not available, at the de
novo event identification step, we recommend pooling
sequencing reads from all the samples. This will enable
identification of the events that lowly expressed in indivi-
dual samples. It will also enable us to identify the events
that have complete inclusion in one condition, but exclu-
sion in another. These events cannot be identified within





We used two RNA-seq datasets for de novo alternative
splicing event identification, human hepatocytes and rat
liver cells. In the human study, primary hepatocytes were
isolated from seven individual subjects, and treated with
Rifampin. Total RNA from both control and treated sam-
ples were extracted. RNA-seq experiments were con-
ducted using the SOLiD 5500×l system with the standard
protocol. In the rat study, RNA-seq experiments were
conducted on liver tissues from 7 non-drinking alcohol-
preferring rats, and 7 alcohol-preferring rats that were
heavily exposed to alcohol for 10 weeks followed by
2 weeks without alcohol. The experiment was conducted
on the SOLiD 4 system with the standard protocol.
Known splicing event annotation
The known alternative splicing event annotation for
human genome was retrieved from the official MISO
library (based on UCSC hg19 assembly). The annotation
file was generated based on transcript annotation using
an EST database; a splicing event was considered alter-
native if it was supported by multiple ESTs.
RNA-seq alignment
We used two RNA-seq alignment pipelines, TopHat [8]
and a customized strategy using BFAST [19] as primary
aligner and known splicing sites documented in UCSC
Known Gene database [23]. TopHat v1.4.0 was used
with standard parameter settings on color space data.
The customized pipeline uses BFAST [19] as a primary
aligner due to its computability with small insertions/
deletions, and reported higher sensitivity on color space
data [20]. The overall alignment of our customized
RNA-seq pipeline includes two levels, alignment on
genomic DNA sequences, and alignment on a junction
library based on all possible exon combinations within a
100,000-bp span, based on documented exon bound-
aries. This is different from TopHat strategy, which uses
sequencing reads enrichment and splicing sequence fea-
tures (GU...AG) for exon boundary detection.
Other algorithms for splicing analysis
Based on the alignment output from TopHat or the cus-
tomized pipeline, Cufflinks v1.2.1 [15] and Scripture [16]
were used for isoform reconstruction. fastMISO (Mixture
of Isoforms) [17] was used to calculate the percentage of
inclusion for annotated and novel alternative splicing
events. Standard parameter settings were used for all the
three programs.
De novo alternative splicing event identification
As shown in Figure 1A, Alt Event Finder uses transcript
isoform annotation from Cufflinks (GTF format) or Scrip-
ture (BED format) as input. The output is the data-derived
alternative event annotation in GFF3 format, which can be
used as MISO input. From the isoform annotation, the Alt
Event Finder extracts “minimum non-overlapping exon
regions” as expression units (Figure 1B), counts the num-
ber of isoforms that include each expression unit, and
further derives appropriate AS events based on the string
of counts (Figure 1B). In this study, we focus on cassette
exons.
Performance assessment
The ability of Alt Event Finder was evaluated by compar-
ing with the splicing event annotation in the MISO
library. Events from two annotations are considered con-
sistent only if the genomic loci of the alternative exon
(cassette exon) and their 5’ upstream and 3’ downstream
exons are identical. This ensures the most conservative
evaluation. The performance of Alt Event Finder is
assessed by using three measurements, the total number
of identified events, and the rate of known events and the
recall of the overall finding. The rate of known events is
defined by the percentage of known events within data-
driven ones, and recall is defined as the percentage of
data-driven events within known ones.
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